On Thursday, October 21, CDC recommended a booster shot of the Moderna and Janssen (Johnson & Johnson) COVID-19 vaccines. See the CDC statement.
These recommendations align with and follow FDA's authorization of:
- The use of Moderna's COVID-19 vaccine to be administered as a booster for certain populations.
- The Janssen (Johnson & Johnson) COVID-19 vaccine for anyone 18 and older who received that vaccine at least 2 months ago.
- The use of all three available COVID-19 vaccines (Moderna, Janssen (Johnson & Johnson), and Pfizer-BioNTech) as “mix and match” boosters for people who have completed their primary vaccination.
The guidelines for COVID-19 boosters vary by vaccine. The following resources are available to help health centers understand what this means and assess readiness:
The following upcoming opportunities can also help clinicians learn more:
-
What Clinicians Need to Know about the Recent Updates to CDC’s Recommendations for COVID-19 Boosters
CDC’s Clinician Outreach and Communication Activity (COCA) Call Tuesday, October 26 2:00-3:00 p.m. ET Join the day of the session
The slides will eventually be available under “Call Materials” on the COCA Call webpage, and a recording will be posted on the page a few hours after the event ends.
-
Today with Macrae: Health Center Program Updates
The webcast will include a segment with Peter Marks, M.D., Ph.D., the director of FDA’s Center for Biologics Evaluation and Research, who will provide the latest guidance for health centers on COVID-19 vaccines and other updates on vaccine safety and efficacy.
Tuesday, November 9 3:00-4:00 p.m. ET Join the day of the session
|